Skip to main content
. Author manuscript; available in PMC: 2020 Sep 1.
Published in final edited form as: Addict Biol. 2018 Jul 18;24(5):908–920. doi: 10.1111/adb.12653

Figure 6. Systemic administration of the CRMP2 inhibitor lacosamide prevents reinstatement of alcohol place preference and does not affect spontaneous locomotor activity.

Figure 6

(a) Mice underwent acquisition and extinction of alcohol place preference as depicted in Figure 1. On day 14, mice were pre-treated with vehicle (Veh) or lacosamide (LCM, 10 mg/kg, i.p.). Ninety minutes later, mice received a priming injection of saline or alcohol (0.9 g/kg, i.p.) and underwent the reinstatement test. (b) CPP score on the post-acquisition (Post-acq.), post-extinction (Post-ext.) and re- instatement (Reinst.) tests. Data are represented as mean percentage ± SEM of time spent in the drug-paired compartment during the tests mi- nus time spent in the same compartment on the pre-acquisition session. (c) Mice were injected with either Veh or LCM (10 mg/kg, i.p.) 90 minutes prior to the beginning of the locomotion test. Data are represented as mean percentage ± SEM of spontaneous locomotor activity measured during 30 minutes. (b) Veh/Sal n = 11, LCM/Sal n = 10, Veh/Alc n = 12, LCM/Alc n = 14, (c) n = 5. (b) ###P < 0.001 versus saline- conditioned mice and *P < 0.05 versus Veh/Alc group. CPP, conditioned place preference